Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (191-200 of 304) with videos related to

Pageof 31
Sort By:
Neurogenetics|November 19, 2013
Rare variants in LRRK1 and Parkinson's diseaseEva C Schulte, Daniel C Ellwanger, Sybille Dihanich, et al.
Neuroepidemiology|November 3, 2015
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PDStefanie Lerche, Inga Liepelt-Scarfone, Guido Alves, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
Risk of Parkinson's disease dementia related to level I MDS PD-MCIJeroen Hoogland, Judith A Boel, Rob M A de Bie, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Annals of Neurology|June 17, 2020
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseDavid J Irwin, Janel Fedler, Christopher S Coffey, et al.
Neurology|August 5, 2020
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson diseaseLana M Chahine, Thomas G Beach, Michael C Brumm, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
NPJ Parkinson'S Disease|July 27, 2021
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's diseaseLuis M A Oliveira, Thomas Gasser, Robert Edwards, et al.
Movement Disorders Clinical Practice|June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyDaniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2024
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven ApproachConnie Marras, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.
Pageof 31

Showing results (191-200 of 304) with videos related to

Sort By:
Pageof 31
Neurogenetics|November 19, 2013
Rare variants in LRRK1 and Parkinson's diseaseEva C Schulte, Daniel C Ellwanger, Sybille Dihanich, et al.
Neuroepidemiology|November 3, 2015
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PDStefanie Lerche, Inga Liepelt-Scarfone, Guido Alves, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
Risk of Parkinson's disease dementia related to level I MDS PD-MCIJeroen Hoogland, Judith A Boel, Rob M A de Bie, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Annals of Neurology|June 17, 2020
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseDavid J Irwin, Janel Fedler, Christopher S Coffey, et al.
Neurology|August 5, 2020
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson diseaseLana M Chahine, Thomas G Beach, Michael C Brumm, et al.
Parkinsonism & Related Disorders|February 11, 2019
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Neha Prakash, Chelsea Caspell-Garcia, Christopher Coffey, et al.
NPJ Parkinson'S Disease|July 27, 2021
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's diseaseLuis M A Oliveira, Thomas Gasser, Robert Edwards, et al.
Movement Disorders Clinical Practice|June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyDaniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 20, 2024
Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven ApproachConnie Marras, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.
Pageof 31